ESR1 and breast carcinoma: Thus, mechanisms that lead to only a partial loss or altered functionality of the LATS proteins might be required to abrogate the RASSF1A-mediated suppression of YAP1, ERα and FOXM1, thereby fostering the initiation and progression of luminal breast cancer.